Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 06-2014 | 12-2013 | 06-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,847 | 5,078 | 834 | 1,279 | 1,656 |
| Marketable Securities | 6,752 | 1,001 | 458 | 857 | 1,431 |
| Inventories | 56 | 57 | 199 | 238 | 72 |
| Other current assets | 157 | 161 | 233 | 199 | 289 |
| TOTAL | $9,812 | $6,297 | $1,724 | $2,573 | $3,448 |
| Non-Current Assets | |||||
| PPE Net | 17 | 16 | 15 | 22 | 27 |
| Intangibles | 102 | 112 | 297 | 318 | 332 |
| TOTAL | $119 | $128 | $312 | $340 | $359 |
| Total Assets | $9,931 | $6,425 | $2,036 | $2,913 | $3,807 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 78 | 1,441 | 20 | 454 | 97 |
| TOTAL | $495 | $1,441 | $457 | $454 | $391 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $495 | $1,441 | $457 | $454 | $391 |
| Shareholders' Equity | |||||
| Common Shares | 913 | 786 | 752 | 752 | 752 |
| Retained earnings | -17,731 | -17,095 | -19,078 | -18,198 | -17,241 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $9,436 | $4,984 | $1,579 | $2,459 | $3,416 |
| Total Liabilities And Equity | $9,931 | $6,425 | $2,036 | $2,913 | $3,807 |